These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18692060)

  • 21. Echinococcus granulosus glycoconjugates induce peritoneal B cell differentiation into antibody-secreting cells and cytokine production.
    Mourglia-Ettlin G; Amezcua-Vesely MC; Fraga R; Baz A; Merino MC; Gruppi A; Dematteis S
    Parasite Immunol; 2011 Nov; 33(11):621-31. PubMed ID: 21992445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status and future prospective of vaccine development against Echinococcus granulosus.
    Pourseif MM; Moghaddam G; Saeedi N; Barzegari A; Dehghani J; Omidi Y
    Biologicals; 2018 Jan; 51():1-11. PubMed ID: 29100669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic echinococcosis: aspects of immune response, immunopathogenesis and immune evasion from the human host.
    Siracusano A; Delunardo F; Teggi A; Ortona E
    Endocr Metab Immune Disord Drug Targets; 2012 Mar; 12(1):16-23. PubMed ID: 22214328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen B from Echinococcus granulosus is a novel ligand for C-reactive protein.
    Silva-Álvarez V; Ramos AL; Folle AM; Lagos S; Dee VM; Ferreira AM
    Parasite Immunol; 2018 Sep; 40(9):e12575. PubMed ID: 30030926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodiagnostic Value of Echinococcus Granulosus Recombinant B8/1 Subunit of Antigen B.
    Savardashtaki A; Sarkari B; Arianfar F; Mostafavi-Pour Z
    Iran J Immunol; 2017 Jun; 14(2):111-122. PubMed ID: 28630382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological reactivity of patients with Echinococcus infections (E. granulosus, E. vogeli, and E. multilocularis) against three antigen B subunits.
    de la Rue ML; Yamano K; Almeida CE; Iesbich MP; Fernandes CD; Goto A; Kouguchi H; Takahashi K
    Parasitol Res; 2010 Feb; 106(3):741-5. PubMed ID: 20066435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
    Hemphill A; Spicher M; Stadelmann B; Mueller J; Naguleswaran A; Gottstein B; Walker M
    Parasitology; 2007 Nov; 134(Pt 12):1657-70. PubMed ID: 17631693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunology of cystic echinococcosis (hydatid disease).
    Díaz Á
    Br Med Bull; 2017 Dec; 124(1):121-133. PubMed ID: 29253150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Echinococcus granulosus microRNAs and their expression in different life cycle stages and parasite genotypes.
    Cucher M; Prada L; Mourglia-Ettlin G; Dematteis S; Camicia F; Asurmendi S; Rosenzvit M
    Int J Parasitol; 2011 Mar; 41(3-4):439-48. PubMed ID: 21219906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Echinococcus granulosus antigen B: a Hydrophobic Ligand Binding Protein at the host-parasite interface.
    Silva-Álvarez V; Folle AM; Ramos AL; Zamarreño F; Costabel MD; García-Zepeda E; Salinas G; Córsico B; Ferreira AM
    Prostaglandins Leukot Essent Fatty Acids; 2015 Feb; 93():17-23. PubMed ID: 25451555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative expression of antigen B coding gene of bubaline isolates of Echinococcus granulosus in fertile and sterile cysts.
    Pan D; Bera AK; Bandyopadhyay S; Das SK; Bandyopadhyay S; Bhattacharyya S; Manna B; De S; Bhattacharya D
    J Helminthol; 2010 Sep; 84(3):241-4. PubMed ID: 19781130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic characterization of larval and adult developmental stages in Echinococcus granulosus reveals novel insight into host-parasite interactions.
    Cui SJ; Xu LL; Zhang T; Xu M; Yao J; Fang CY; Feng Z; Yang PY; Hu W; Liu F
    J Proteomics; 2013 Jun; 84():158-75. PubMed ID: 23603110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunology of Alveolar and Cystic Echinococcosis (AE and CE).
    Gottstein B; Soboslay P; Ortona E; Wang J; Siracusano A; Vuitton DΑ
    Adv Parasitol; 2017; 96():1-54. PubMed ID: 28212788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydatid fluid from
    Chop M; Ledo C; Nicolao MC; Loos J; Cumino A; Rodriguez Rodrigues C
    Front Cell Infect Microbiol; 2024; 14():1334211. PubMed ID: 38817444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinococcosis and allergy.
    Vuitton DA
    Clin Rev Allergy Immunol; 2004 Apr; 26(2):93-104. PubMed ID: 15146106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease?
    Zhang W; McManus DP
    Trends Parasitol; 2008 Sep; 24(9):419-24. PubMed ID: 18678528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in interferon-gamma and nitric oxide levels in human echinococcosis.
    Ait Aissa S; Amri M; Bouteldja R; Wietzerbin J; Touil-Boukoffa C
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):65-70. PubMed ID: 16914097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echinococcus.
    Bhatia G
    Semin Respir Infect; 1997 Jun; 12(2):171-86. PubMed ID: 9195682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunogenicity of Echinococcus granulosus antigen 5 is determined by its post-translational modifications.
    Lorenzo C; Last JA; González-Sapienza GG
    Parasitology; 2005 Nov; 131(Pt 5):669-77. PubMed ID: 16255825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics analysis of EgA31 and EgG1Y162 proteins for designing a multi-epitope vaccine against Echinococcus granulosus.
    Zhao X; Zhang F; Li Z; Wang H; An M; Li Y; Pang N; Ding J
    Infect Genet Evol; 2019 Sep; 73():98-108. PubMed ID: 31022474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.